Literature DB >> 17600025

Routine testing to reduce late HIV diagnosis in France.

Cyrille Delpierre1, Lise Cuzin, France Lert.   

Abstract

Mesh：

Year:  2007        PMID： 17600025      PMCID： PMC1906674          DOI： 10.1136/bmj.39225.458218.94

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  17 in total

1.  Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial.

Authors:  J Cook; E Dasbach; P Coplan; L Markson; D Yin; A Meibohm; B Y Nguyen; J Chodakewitz; J Mellors
Journal:  AIDS Res Hum Retroviruses       Date:  1999-04-10       Impact factor: 2.205

2.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

3.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

4.  A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV.

Authors:  I de Vincenzi
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

5.  Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Authors:  Gillian D Sanders; Ahmed M Bayoumi; Vandana Sundaram; S Pinar Bilir; Christopher P Neukermans; Chara E Rydzak; Lena R Douglass; Laura C Lazzeroni; Mark Holodniy; Douglas K Owens
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

6.  Late versus early testing of HIV--16 Sites, United States, 2000-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-06-27       Impact factor: 17.586

7.  Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy.

Authors:  Yazdan Yazdanpanah; Sue J Goldie; Elena Losina; Milton C Weinstein; Thérèse Lebrun; A David Paltiel; George R Seage; Garmenick Leblanc; Faisa Ajana; April D Kimmel; Hong Zhang; Roger Salamon; Yves Mouton; Kenneth A Freedberg
Journal:  Antivir Ther       Date:  2002-12

8.  The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection.

Authors:  H B Krentz; M C Auld; M J Gill
Journal:  HIV Med       Date:  2004-03       Impact factor: 3.180

9.  Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group.

Authors:  M L Kamb; M Fishbein; J M Douglas; F Rhodes; J Rogers; G Bolan; J Zenilman; T Hoxworth; C K Malotte; M Iatesta; C Kent; A Lentz; S Graziano; R H Byers; T A Peterman
Journal:  JAMA       Date:  1998-10-07       Impact factor: 56.272

10.  The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group.

Authors: 
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728
View more
  7 in total

1.  Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition.

Authors:  S MacCarthy; D R Bangsberg; G Fink; M Reich; S Gruskin
Journal:  HIV Med       Date:  2013-09-11       Impact factor: 3.180

2.  Reducing the length of time between HIV infection and diagnosis.

Authors:  Catherine Dodds; Peter Weatherburn
Journal:  BMJ       Date:  2007-06-30

3.  Increasing late diagnosis in HIV infection in South Korea: 2000-2007.

Authors:  Jin-Hee Lee; Gab Jung Kim; Byeong-Sun Choi; Kee-Jong Hong; Mi-Kyung Heo; Sung Soon Kim; Mee-Kyung Kee
Journal:  BMC Public Health       Date:  2010-07-13       Impact factor: 3.295

4.  Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007.

Authors:  Bakhao Ndiaye; Julia Salleron; Anne Vincent; Pierre Bataille; Frédérique Bonnevie; Philippe Choisy; Karine Cochonat; Clotilde Fontier; Habib Guerroumi; Bernard Vandercam; Hugues Melliez; Yazdan Yazdanpanah
Journal:  BMC Infect Dis       Date:  2011-01-12       Impact factor: 3.090

5.  Which adults in the Paris metropolitan area have never been tested for HIV? A 2010 multilevel, cross-sectional, population-based study.

Authors:  Véronique Massari; Annabelle Lapostolle; Marie-Catherine Grupposo; Rosemary Dray-Spira; Dominique Costagliola; Pierre Chauvin
Journal:  BMC Infect Dis       Date:  2015-07-22       Impact factor: 3.090

6.  Understanding Reasons for HIV Late Diagnosis: A Qualitative Study Among HIV-Positive Individuals in Amsterdam, The Netherlands.

Authors:  Maarten Bedert; Udi Davidovich; Godelieve de Bree; Ward van Bilsen; Ard van Sighem; Wim Zuilhof; Kees Brinkman; Marc van der Valk; John de Wit
Journal:  AIDS Behav       Date:  2021-03-31

7.  "Late for testing, early for antiretroviral therapy, less likely to die": results from a large HIV cohort study in China, 2006-2014.

Authors:  Houlin Tang; Yurong Mao; Weiming Tang; Jing Han; Juan Xu; Jian Li
Journal:  BMC Infect Dis       Date:  2018-06-13       Impact factor: 3.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.